Literature DB >> 24770974

The importance of nitric oxide and arginase in the pathogenesis of acute neuroinflammation: are those contra players with the same direction?

Srdjan Ljubisavljevic1, Ivana Stojanovic, Radmila Pavlovic, Dusica Pavlovic.   

Abstract

To investigate the concentrations of nitric oxide (NO) products (NOx) and arginase activity in acute neuroinflammation, we analyzed cerebrospinal fluid (CSF) and plasma of clinically isolated syndrome (CIS) and relapsing remitting multiple sclerosis (RRMS) patients, who were divided into groups on the basis of clinical and radiological disease activity. The NOx levels, in both, CSF and plasma, were increased in CIS (p = 0.0015, p = 0.0014, respectively) and RRMS group (p = 0.002, p = 0.0019, respectively), while arginase activity approached low levels, in CIS (p = 0.009, p = 0.02, respectively) and RRMS group (p = 0.018, p = 0.034, respectively) compared to controls. The NOx levels were higher in CSF and plasma of CIS than in RRMS group (p = 0.065, p = 0.037, respectively), inverse to arginase activity which was higher, in CSF and plasma, in RRMS than in CIS group (p = 0.031, p = 0.02, respectively). The CSF and plasma NOx values positively correlated with the clinical disease activity in CIS (r = 0.09, p = 0.81; r = 0.45, p = 0.023, respectively) and RRMS group (r = 0.311, p = 0.04; r = 0.512, p = 0.01, respectively). Also, CSF and plasma arginase activity showed negative correlation with clinical disease activity in CIS (r = 0.39, p = 0.03; r = 0.1, p = 0.65, respectively) and RRMS group (r = 0.43, p = 0.03; r = 0.62, p = 0.015, respectively). The CSF NOx levels showed positive correlation with volume of acute radiological lesions of CNS in CIS (r = 0.25, p = 0.045) and RRMS group (r = 0.31, p = 0.04), while arginase activity showed the negative correlations in CIS (r = 0.41; p = 0.035) and RRMS group (r = 0.52, p = 0.022). The results support NO and arginase involvement in the pathogenesis of acute neuroinflammation, which determination may be useful as surrogate markers for clinical and radiological disease activity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24770974     DOI: 10.1007/s12640-014-9470-3

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  45 in total

1.  Axonal injury in multiple sclerosis.

Authors:  H Lassmann
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-06       Impact factor: 10.154

Review 2.  Alternatively activated macrophages in spinal cord injury and remission: another mechanism for repair?

Authors:  Taekyun Shin; Meejung Ahn; Changjong Moon; Seungjoon Kim; Ki-Bum Sim
Journal:  Mol Neurobiol       Date:  2013-01-16       Impact factor: 5.590

3.  Modulation of nitric oxide synthase by arginase and methylated arginines during the acute phase of experimental multiple sclerosis.

Authors:  Srdjan Ljubisavljevic; Ivana Stojanovic; Radmila Pavlovic; Dusan Sokolovic; Dusica Pavlovic; Tatjana Cvetkovic; Ivana Stevanovic
Journal:  J Neurol Sci       Date:  2012-04-15       Impact factor: 3.181

4.  Exposure to a dysfunctional glucocorticoid receptor from early embryonic life programs the resistance to experimental autoimmune encephalomyelitis via nitric oxide-induced immunosuppression.

Authors:  Bianca Marchetti; Maria C Morale; Jantien Brouwer; Cataldo Tirolo; Nuccio Testa; Salvo Caniglia; Nicholas Barden; Sandra Amor; Paul A Smith; Christine D Dijkstra
Journal:  J Immunol       Date:  2002-06-01       Impact factor: 5.422

5.  Potential role of fibronectin in microglia/macrophage activation following cryoinjury in the rat brain: an immunohistochemical study.

Authors:  Heechul Kim; Meejung Ahn; Sungyoung Choi; Minsoo Kim; Ki-Bum Sim; Juhwan Kim; Changjong Moon; Taekyun Shin
Journal:  Brain Res       Date:  2013-02-01       Impact factor: 3.252

6.  Translational control of inducible nitric oxide synthase by IL-13 and arginine availability in inflammatory macrophages.

Authors:  Stefan El-Gayar; Heike Thüring-Nahler; Josef Pfeilschifter; Martin Röllinghoff; Christian Bogdan
Journal:  J Immunol       Date:  2003-11-01       Impact factor: 5.422

7.  Arginase and autoimmune inflammation in the central nervous system.

Authors:  Lingyun Xu; Brendan Hilliard; Ruaidhrí J Carmody; Galit Tsabary; Hyunshun Shin; David W Christianson; Youhai H Chen
Journal:  Immunology       Date:  2003-09       Impact factor: 7.397

Review 8.  Arginine in asthma and lung inflammation.

Authors:  Nina E King; Marc E Rothenberg; Nives Zimmermann
Journal:  J Nutr       Date:  2004-10       Impact factor: 4.798

9.  Cerebrospinal fluid brain specific proteins in relation to nitric oxide metabolites during relapse of multiple sclerosis.

Authors:  K Rejdak; A Petzold; Z Stelmasiak; G Giovannoni
Journal:  Mult Scler       Date:  2007-09-24       Impact factor: 6.312

10.  Mechanism of experimental autoimmune encephalomyelitis in Lewis rats: recent insights from macrophages.

Authors:  Taekyun Shin; Meejung Ahn; Yoh Matsumoto
Journal:  Anat Cell Biol       Date:  2012-09-30
View more
  9 in total

Review 1.  Arginase: an old enzyme with new tricks.

Authors:  Ruth B Caldwell; Haroldo A Toque; S Priya Narayanan; R William Caldwell
Journal:  Trends Pharmacol Sci       Date:  2015-04-27       Impact factor: 14.819

Review 2.  The potential roles of amino acids and their major derivatives in the management of multiple sclerosis.

Authors:  Somayeh Pashaei; Reza Yarani; Pantea Mohammadi; Mohammad Sajad Emami Aleagha
Journal:  Amino Acids       Date:  2022-04-26       Impact factor: 3.520

Review 3.  Arginase: A Multifaceted Enzyme Important in Health and Disease.

Authors:  R William Caldwell; Paulo C Rodriguez; Haroldo A Toque; S Priya Narayanan; Ruth B Caldwell
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

4.  Systemic lipopolysaccharide-mediated alteration of cortical neuromodulation involves increases in monoamine oxidase-A and acetylcholinesterase activity.

Authors:  Zhi Ming; Caitlin A Wotton; Robert T Appleton; John C Ching; Matthew E Loewen; Grzegorz Sawicki; Lane K Bekar
Journal:  J Neuroinflammation       Date:  2015-02-25       Impact factor: 8.322

5.  Copper amine oxidase 8 regulates arginine-dependent nitric oxide production in Arabidopsis thaliana.

Authors:  Felicitas Groß; Eva-Esther Rudolf; Björn Thiele; Jörg Durner; Jeremy Astier
Journal:  J Exp Bot       Date:  2017-04-01       Impact factor: 6.992

6.  Assessment of Serum Nitrogen Species and Inflammatory Parameters in Relapsing-Remitting Multiple Sclerosis Patients Treated with Different Therapeutic Approaches.

Authors:  Natalia Niedziela; Monika Adamczyk-Sowa; Jacek T Niedziela; Bogdan Mazur; Ewa Kluczewska; Paweł Sowa; Mariusz Gąsior
Journal:  Biomed Res Int       Date:  2016-12-19       Impact factor: 3.411

7.  Impact of suitable control on a uniform interpretation of units for arginase assay.

Authors:  Mishra Suman; Mishra Rajnikant
Journal:  Biochem Biophys Rep       Date:  2021-01-17

8.  Low-dose ribavirin treatments attenuate neuroinflammatory activation of BV-2 Cells by interfering with inducible nitric oxide synthase.

Authors:  Iva Bozic; Danijela Savic; Marija Jovanovic; Ivana Bjelobaba; Danijela Laketa; Nadezda Nedeljkovic; Mirjana Stojiljkovic; Sanja Pekovic; Irena Lavrnja
Journal:  Anal Cell Pathol (Amst)       Date:  2015-08-27       Impact factor: 2.916

9.  KCl-Dependent Release of Mitochondrial Membrane-Bound Arginase Appears to Be a Novel Variant of Arginase-II.

Authors:  Mishra Suman; Mishra Rajnikant
Journal:  Scientifica (Cairo)       Date:  2016-05-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.